<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="rcr270274" xml:lang="en" article-type="case-study"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Respirol Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">Respirol Case Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2051-3380</journal-id><journal-id journal-id-type="publisher-id">RCR2</journal-id><journal-title-group><journal-title>Respirology Case Reports</journal-title></journal-title-group><issn pub-type="epub">2051-3380</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Ltd</publisher-name><publisher-loc>Chichester, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">12371123</article-id><article-id pub-id-type="doi">10.1002/rcr2.70274</article-id><article-id pub-id-type="publisher-id">RCR270274</article-id><article-id pub-id-type="other">RCR-25-227.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>
<styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19 Vaccine&#x02010;Induced Severe Pneumonitis</article-title></title-group><contrib-group><contrib id="rcr270274-cr-0001" contrib-type="author"><name><surname>Suzuki</surname><given-names>Tatsuro</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0001-9412-4447</contrib-id><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="rcr270274-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="rcr270274-cr-0002" contrib-type="author" corresp="yes"><name><surname>Furuta</surname><given-names>Hiromi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7027-0354</contrib-id><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>hiromifuruta1480@gmail.com</email></address></contrib><contrib id="rcr270274-cr-0003" contrib-type="author"><name><surname>Naganawa</surname><given-names>Misa</given-names></name><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="rcr270274-cr-0004" contrib-type="author"><name><surname>Hayashi</surname><given-names>Keiko</given-names></name><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="rcr270274-cr-0005" contrib-type="author"><name><surname>Kiyotoshi</surname><given-names>Hiroko</given-names></name><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="rcr270274-cr-0006" contrib-type="author"><name><surname>Ohta</surname><given-names>Chiharu</given-names></name><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="rcr270274-cr-0007" contrib-type="author"><name><surname>Ninomiya</surname><given-names>Shigemitsu</given-names></name><xref rid="rcr270274-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="rcr270274-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Respiratory Medicine</named-content>
<institution>Toyokawa City Hospital</institution>
<city>Toyokawa City</city>
<country country="JP">Japan</country>
</aff><aff id="rcr270274-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Respiratory Medicine, Allergy and Clinical Immunology</named-content>
<institution>Nagoya City University Graduate School of Medical Sciences</institution>
<city>Nagoya City</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Hiromi Furuta (<email>hiromifuruta1480@gmail.com</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2025</year></pub-date><volume>13</volume><issue seq="305">8</issue><issue-id pub-id-type="doi">10.1002/rcr2.v13.8</issue-id><elocation-id>e70274</elocation-id><history>
<date date-type="rev-recd"><day>26</day><month>6</month><year>2025</year></date>
<date date-type="received"><day>03</day><month>6</month><year>2025</year></date>
<date date-type="accepted"><day>03</day><month>7</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Asian Pacific Society of Respirology--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Respirology Case Reports</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:RCR2-13-e70274.pdf"/><abstract><title>ABSTRACT</title><p>Coronavirus disease 2019 (COVID&#x02010;19) has resulted in global morbidity, mortality, and societal disruption. COVID&#x02010;19 mRNA vaccination was mandatory in many countries for a period; however, severe adverse events have been observed in some individuals who received the vaccine. We report a case of COVID&#x02010;19 mRNA vaccine&#x02010;induced pneumonitis in a male patient whose cytokine levels were analysed prior to admission. His serum IgE level was high (347&#x02009;U/mL), and several cytokines were elevated: TNF&#x003b1; was 1.2&#x02009;pg/mL, IL&#x02010;6 was 156&#x02009;pg/mL, and IL&#x02010;8 was 75.0&#x02009;pg/mL. The patient developed severe respiratory failure requiring ventilatory support but recovered after steroid pulse therapy.</p></abstract><abstract abstract-type="graphical"><p>We report a case of COVID&#x02010;19 mRNA vaccine&#x02010;induced pneumonitis in a male patient whose cytokine levels were analysed prior to admission. We examined his serum cytokine levels: TNF&#x003b1; was 1.2&#x02009;pg/mL, IL&#x02010;6 was 156&#x02009;pg/mL, and IL&#x02010;8 was 75.0&#x02009;pg/mL. The patient developed severe respiratory failure requiring ventilatory support but recovered after steroid pulse therapy.<boxed-text position="anchor" content-type="graphic" id="rcr270274-blkfxd-0001"><graphic xlink:href="RCR2-13-e70274-g003.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="rcr270274-kwd-0001">
<styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19</kwd><kwd id="rcr270274-kwd-0002">cytokine</kwd><kwd id="rcr270274-kwd-0003">interstitial pneumonia</kwd><kwd id="rcr270274-kwd-0004">vaccine</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="4"/><word-count count="1600"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>August 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.0 mode:remove_FC converted:22.08.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="rcr270274-cit-1001">
<string-name>
<given-names>T.</given-names>
<surname>Suzuki</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Furuta</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Naganawa</surname>
</string-name>, et al., &#x0201c;<article-title>
<styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19 Vaccine&#x02010;Induced Severe Pneumonitis</article-title>,&#x0201d; <source>Respirology Case Reports</source>
<volume>13</volume>, no. <issue>8</issue> (<year>2025</year>): <elocation-id>e70274</elocation-id>, <pub-id pub-id-type="doi">10.1002/rcr2.70274</pub-id>.</mixed-citation>
</p><fn-group id="rcr270274-ntgp-0001"><fn fn-type="associateEditor" id="rcr270274-note-0001"><p>
<bold>Associate Editor:</bold> Bei He</p></fn></fn-group></notes></front><body id="rcr270274-body-0001"><sec id="rcr270274-sec-0001"><label>1</label><title>Introduction</title><p>Severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2) has killed more than 14 million people [<xref rid="rcr270274-bib-0001" ref-type="bibr">1</xref>]. The global pandemic and social disruption prompted the accelerated clinical application of COVID&#x02010;19 vaccines worldwide [<xref rid="rcr270274-bib-0002" ref-type="bibr">2</xref>]. Since December 8, 2020, emergency use authorisation of mRNA vaccines (such as BNT162b2 (Pfizer&#x02010;BioNTech) and mRNA&#x02010;1273 (Moderna)) has been granted, and vaccination became compulsory in many countries. COVID&#x02010;19 mRNA vaccines are highly effective in preventing severe COVID&#x02010;19 and have contributed to pandemic control. However, the vaccines were rapidly approved, and unlike other investigational drugs, limited safety data had been accumulated. According to clinical trial data, most vaccine&#x02010;associated adverse events are mild [<xref rid="rcr270274-bib-0002" ref-type="bibr">2</xref>]; however, severe adverse reactions such as anaphylaxis, myocarditis, and thrombotic events have also been reported [<xref rid="rcr270274-bib-0003" ref-type="bibr">3</xref>]. These events can be fatal, and their mechanisms remain poorly understood. Pneumonitis following COVID&#x02010;19 vaccination is rare.</p><p>We report a case of severe pneumonitis as an adverse event of COVID&#x02010;19 vaccination. The patient recovered after steroid pulse therapy. His blood cytokine data before admission were examined. There have been few reports of cytokine analysis in acute vaccine&#x02010;related adverse events (AEs). We hope our report contributes to future cytokine research and therapy for vaccine&#x02010;related AEs.</p></sec><sec id="rcr270274-sec-0002"><label>2</label><title>Case Report</title><p>A 77&#x02010;year&#x02010;old male ex&#x02010;smoker with a 30&#x02010;pack&#x02010;year history was admitted to our hospital with severe respiratory failure. He had no history of chronic interstitial lung disease and allergies. He had received his third dose of the COVID&#x02010;19 vaccine (BNT162b2, Pfizer) 2&#x02009;days prior. Computed tomography (CT) revealed multiple ground&#x02010;glass opacities with traction bronchiectasis in both lungs (Figure&#x000a0;<xref rid="rcr270274-fig-0001" ref-type="fig">1A&#x02013;C</xref>). On admission, his body temperature was 37.4&#x000b0;C, and oxygen saturation was 95% on nasal oxygen at 4&#x02009;L/min. Significant pathogens were not detected and the quantitative test for COVID&#x02010;19 antigen was negative (Table&#x000a0;<xref rid="rcr270274-tbl-0001" ref-type="table">1</xref>). Chlamydophila pneumonia IgG and IgA were both positive, but the result indicated past infection (Table&#x000a0;<xref rid="rcr270274-tbl-0001" ref-type="table">1</xref>). His condition deteriorated in the emergency department, with oxygen saturation barely reaching 90% despite 10&#x02009;L/min oxygen; therefore, invasive mechanical ventilation was initiated, and steroid pulse therapy was administered. As the aetiology of pneumonitis was unclear, antibiotic therapy (pazufloxacin, 1000&#x02009;mg twice daily) was started under the suspicion of atypical pneumonia. The patient was admitted to the intensive care unit (ICU).</p><fig position="float" fig-type="FIGURE" id="rcr270274-fig-0001"><label>FIGURE 1</label><caption><p>Chest x&#x02010;ray and CT findings on admission (a&#x02013;c) and 2&#x02009;days after admission (d&#x02013;f).</p></caption><graphic xlink:href="RCR2-13-e70274-g002" position="anchor" id="jats-graphic-3"/></fig><table-wrap position="float" id="rcr270274-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Laboratory data of this case at admission.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Laboratory data</th><th align="center" valign="bottom" rowspan="1" colspan="1">Value</th><th align="center" valign="bottom" rowspan="1" colspan="1">Unit</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Haematology</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">White blood cell</td><td align="center" valign="top" rowspan="1" colspan="1">9200</td><td align="center" valign="top" rowspan="1" colspan="1">/&#x003bc;L</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Neutrophils</td><td align="center" valign="top" rowspan="1" colspan="1">82.1</td><td align="center" valign="top" rowspan="1" colspan="1">%</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Lymphocytes</td><td align="center" valign="top" rowspan="1" colspan="1">10.7</td><td align="center" valign="top" rowspan="1" colspan="1">%</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Eosinophils</td><td align="center" valign="top" rowspan="1" colspan="1">0.8</td><td align="center" valign="top" rowspan="1" colspan="1">%</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Basophils</td><td align="center" valign="top" rowspan="1" colspan="1">0.1</td><td align="center" valign="top" rowspan="1" colspan="1">%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serology</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CRP</td><td align="center" valign="top" rowspan="1" colspan="1">11.3</td><td align="center" valign="top" rowspan="1" colspan="1">mg/dL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">KL&#x02010;6</td><td align="center" valign="top" rowspan="1" colspan="1">597</td><td align="center" valign="top" rowspan="1" colspan="1">U/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">BNP</td><td align="center" valign="top" rowspan="1" colspan="1">242</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Anti&#x02010;ARS Ab</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;5.0</td><td align="center" valign="top" rowspan="1" colspan="1">index</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&#x003b2;&#x02010;D&#x02010;glucan</td><td align="center" valign="top" rowspan="1" colspan="1">4.4</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ANA</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;40</td><td align="center" valign="top" rowspan="1" colspan="1">fold</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total IgE</td><td align="center" valign="top" rowspan="1" colspan="1">347</td><td align="center" valign="top" rowspan="1" colspan="1">U/mL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Blood gas analysis (4&#x02009;L/min)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">pH</td><td align="center" valign="top" rowspan="1" colspan="1">7.495</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PaCO<sub>2</sub>
</td><td align="center" valign="top" rowspan="1" colspan="1">27.8</td><td align="center" valign="top" rowspan="1" colspan="1">Torr</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PaO<sub>2</sub>
</td><td align="center" valign="top" rowspan="1" colspan="1">60.0</td><td align="center" valign="top" rowspan="1" colspan="1">Torr</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-1" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mi>HC</mml:mi><mml:msubsup><mml:mi mathvariant="normal">O</mml:mi><mml:mn>3</mml:mn><mml:mo>&#x02212;</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:mrow></mml:math>
</td><td align="center" valign="top" rowspan="1" colspan="1">21.4</td><td align="center" valign="top" rowspan="1" colspan="1">mmol/L</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytokine</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IFN&#x003b3;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.1</td><td align="center" valign="top" rowspan="1" colspan="1">IU/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IL&#x02010;1&#x003b2;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;10</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IL&#x02010;5</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;4</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IL&#x02010;6</td><td align="center" valign="top" rowspan="1" colspan="1">156</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IL&#x02010;8</td><td align="center" valign="top" rowspan="1" colspan="1">75.0</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TNF&#x02010;&#x003b1;</td><td align="center" valign="top" rowspan="1" colspan="1">1.2</td><td align="center" valign="top" rowspan="1" colspan="1">pg/mL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Infection panel</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Quantitative COVID&#x02010;19 antigen</td><td align="center" valign="top" rowspan="1" colspan="1">0.01 (Negative)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sputum bacterial culture</td><td align="center" valign="top" rowspan="1" colspan="1">Negative</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Urinary pneumococcal antigen</td><td align="center" valign="top" rowspan="1" colspan="1">Negative</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Urinary legionella antigen</td><td align="center" valign="top" rowspan="1" colspan="1">Negative</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<styled-content style="fixed-case" toggle="no">
<italic toggle="no">C. pneumoniae</italic>
</styled-content> IgG (baseline data)</td><td align="center" valign="top" rowspan="1" colspan="1">48 (94)</td><td align="center" valign="top" rowspan="1" colspan="1">titre</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">
<styled-content style="fixed-case" toggle="no">
<italic toggle="no">C. pneumoniae</italic>
</styled-content> IgA (baseline data)</td><td align="center" valign="top" rowspan="1" colspan="1">16 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">titre</td></tr></tbody></table><table-wrap-foot id="rcr270274-ntgp-0002"><fn id="rcr270274-note-0002"><p>Abbreviations: ANA: antinuclear antibody; ARS: aminoacyl tRNA synthetase; BNP: brain natriuretic peptide; <styled-content style="fixed-case" toggle="no">
<italic toggle="no">C. pneumoniae</italic>
</styled-content>: <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Chlamydophila pneumoniae</italic>
</styled-content>; COVID&#x02010;19: coronavirus disease 2019; CRP: C&#x02010;reactive protein; IFN&#x02010;&#x003b3;: interferon gamma; IgA: immunoglobulin A; IgG: immunoglobulin G; IL: interleukin; KL&#x02010;6: Krebs von den Lungen&#x02010;6; TNF: tumour necrosis factor.</p></fn></table-wrap-foot></table-wrap><p>The patient received steroid pulse therapy for 4&#x02009;days and recovered from respiratory failure. Antibiotic therapy was completed 5&#x02009;days after admission. He was successfully weaned off ventilatory support and discharged from the ICU 6&#x02009;days after admission. Corticosteroids were gradually tapered, and complete recovery was achieved within 2&#x02009;weeks (Figure&#x000a0;<xref rid="rcr270274-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="FIGURE" id="rcr270274-fig-0002"><label>FIGURE 2</label><caption><p>Timeline of chest x&#x02010;ray and CRP levels in relation to steroid therapy.</p></caption><graphic xlink:href="RCR2-13-e70274-g001" position="anchor" id="jats-graphic-5"/></fig><p>Pre&#x02010;admission laboratory tests (Table&#x000a0;<xref rid="rcr270274-tbl-0001" ref-type="table">1</xref>) showed a mildly elevated white blood cell count (9200/&#x003bc;L), with neutrophils at 82.1%, lymphocytes at 10.7%, and eosinophils at 0.8%. The serum KL&#x02010;6 level was normal, but C&#x02010;reactive protein (CRP) was elevated (11.3&#x02009;mg/dL). All microbiological and immunological test results were negative.</p><p>Cytokine levels from pre&#x02010;admission serum were analysed (Table&#x000a0;<xref rid="rcr270274-tbl-0001" ref-type="table">1</xref>). IFN&#x02010;&#x003b3;, IL&#x02010;1&#x003b2;, TNF&#x02010;&#x003b1;, and IL&#x02010;5 levels were within normal range, whereas IL&#x02010;6, IL&#x02010;8, and TNF&#x02010;&#x003b1; were elevated (TNF&#x02010;&#x003b1;: 1.2&#x02009;pg/mL; IL&#x02010;6: 156&#x02009;pg/mL; IL&#x02010;8: 75.0&#x02009;pg/mL). IgE was slightly elevated (347&#x02009;U/mL).</p></sec><sec sec-type="discussion" id="rcr270274-sec-0003"><label>3</label><title>Discussion</title><p>In this case, the patient developed severe pneumonitis following COVID&#x02010;19 vaccination, and we evaluated cytokine dynamics during steroid therapy.</p><p>Analysis of circulating cytokines revealed markedly elevated IL&#x02010;8, IL&#x02010;6, and TNF&#x02010;&#x003b1; levels. In contrast, IL&#x02010;5, which plays a key role in allergic eosinophilic inflammation, was not elevated. However, the patient's IgE level was mildly elevated, suggesting a partial allergic response. Elevated IL&#x02010;8 has been reported in IgE&#x02010;mediated lung disease [<xref rid="rcr270274-bib-0004" ref-type="bibr">4</xref>], supporting the possibility of an overlapping allergic component.</p><p>Meanwhile, IL&#x02010;6 and IL&#x02010;8 are also known mediators of systemic inflammation and cell&#x02010;mediated immune activation. Therefore, we speculate that this patient exhibited a mixed immune reaction&#x02014;both allergic and inflammatory.</p><p>The mechanisms underlying allergic reactions to COVID&#x02010;19 vaccines remain poorly understood, and the number of documented cases is limited. Greenhawt et&#x000a0;al. reported a very low incidence of vaccine&#x02010;associated anaphylaxis (7.91 per million doses) [<xref rid="rcr270274-bib-0005" ref-type="bibr">5</xref>]. Lipid nanoparticles (LNPs), including polyethylene glycol and polysorbate, have been implicated in vaccine&#x02010;induced hypersensitivity and inflammatory reactions [<xref rid="rcr270274-bib-0005" ref-type="bibr">5</xref>].</p><p>COVID&#x02010;19 mRNA vaccines encode the spike protein receptor&#x02010;binding domain (RBD) of SARS&#x02010;CoV&#x02010;2, prompting its expression on host cells to generate an immune response. The production of anti&#x02010;RBD antibodies not only protects against infection but may also enhance innate immunity. These antibodies may contribute to exaggerated immune responses, including systemic inflammation. Bergamaschi et&#x000a0;al. reported that the second dose of BNT162b2 mRNA vaccine led to a sharp rise in cytokine levels, such as TNF&#x02010;&#x003b1; and IL&#x02010;6. Other studies have associated COVID&#x02010;19 vaccination with autoimmune manifestations and cytokine release syndrome. Together, these findings suggest that vaccination can stimulate various immune pathways, potentially leading to allergic&#x02010;like reactions and vaccine&#x02010;related pneumonitis.</p><p>In our case, cytokine assessment was limited by insurance restrictions in Japan, and bronchoscopy could not be performed due to rapid respiratory decline. Nevertheless, the observed elevations in cytokines and IgE support a vaccine&#x02010;related immune complication. Understanding these immunologic patterns may help guide treatment of future COVID&#x02010;19 vaccine&#x02010;related AEs.</p></sec><sec id="rcr270274-sec-0004"><title>Author Contributions</title><p>
<bold>Tatsuro Suzuki:</bold> investigation, writing, review, and editing. <bold>Hiromi Furuta:</bold> conceptualisation, investigation, writing, review, and editing. <bold>Misa Naganawa</bold> and <bold>Keiko Hayashi:</bold> investigation, review, and editing. <bold>Hiroko Kiyotoshi:</bold> review and editing. <bold>Chiharu Ohta</bold> and <bold>Shigemitsu Ninomiya:</bold> review, editing, and supervision.</p></sec><sec sec-type="conclusions" id="rcr270274-sec-0006"><title>Consent</title><p>The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images using the consent form provided by the Journal.</p></sec><sec sec-type="COI-statement" id="rcr270274-sec-0007"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><ack id="rcr270274-sec-0005"><title>Acknowledgments</title><p>The authors would like to express their gratitude to Dr. Hori Fabien for writing this paper. His support was invaluable in the successful completion of the case report.</p></ack><sec sec-type="data-availability" id="rcr270274-sec-0009"><title>Data Availability Statement</title><p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></sec><ref-list content-type="cited-references" id="rcr270274-bibl-0001"><title>References</title><ref id="rcr270274-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="rcr270274-cit-0001">
<string-name>
<given-names>W.</given-names>
<surname>Msemburi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Karlinsky</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Knutson</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Aleshin&#x02010;Guendel</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chatterji</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Wakefield</surname>
</string-name>, &#x0201c;<article-title>The WHO Estimates of Excess Mortality Associated With the COVID&#x02010;19 Pandemic</article-title>,&#x0201d; <source>Nature</source>
<volume>613</volume>, no. <issue>7942</issue> (<year>2023</year>): <fpage>130</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">36517599</pub-id>
</mixed-citation></ref><ref id="rcr270274-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="rcr270274-cit-0002">
<string-name>
<given-names>F. P.</given-names>
<surname>Polack</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Thomas</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Kitchin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Safety and Efficacy of the BNT162b2 mRNA COVID&#x02010;19 Vaccine</article-title>,&#x0201d; <source>New England Journal of Medicine</source>
<volume>383</volume>, no. <issue>27</issue> (<year>2020</year>): <fpage>2603</fpage>&#x02013;<lpage>2615</lpage>.<pub-id pub-id-type="pmid">33301246</pub-id>
</mixed-citation></ref><ref id="rcr270274-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="rcr270274-cit-0003">
<string-name>
<given-names>M.</given-names>
<surname>Lamprinou</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sachinidis</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Stamoula</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Vavilis</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Papazisis</surname>
</string-name>, &#x0201c;<article-title>COVID&#x02010;19 Vaccines Adverse Events: Potential Molecular Mechanisms</article-title>,&#x0201d; <source>Immunologic Research</source>
<volume>71</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>356</fpage>&#x02013;<lpage>372</lpage>.<pub-id pub-id-type="pmid">36607502</pub-id>
</mixed-citation></ref><ref id="rcr270274-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="rcr270274-cit-0004">
<string-name>
<given-names>R.</given-names>
<surname>Erger</surname>
</string-name> and <string-name>
<given-names>T.</given-names>
<surname>Casale</surname>
</string-name>, &#x0201c;<article-title>Interleukin&#x02010;8 Plays a Significant Role in IgE&#x02010;Mediated Lung Inflammation</article-title>,&#x0201d; <source>European Respiratory Journal</source>
<volume>11</volume>, no. <issue>2</issue> (<year>1998</year>): <fpage>299</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">9551728</pub-id>
</mixed-citation></ref><ref id="rcr270274-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="rcr270274-cit-0005">
<string-name>
<given-names>M.</given-names>
<surname>Greenhawt</surname>
</string-name>, <string-name>
<given-names>E. M.</given-names>
<surname>Abrams</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Shaker</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Risk of Allergic Reaction to SARS&#x02010;CoV&#x02010;2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta&#x02010;Analysis, GRADE Assessment, and International Consensus Approach</article-title>,&#x0201d; <source>Journal of Allergy and Clinical Immunology. In Practice</source>
<volume>9</volume>, no. <issue>10</issue> (<year>2021</year>): <fpage>3546</fpage>&#x02013;<lpage>3567</lpage>.<pub-id pub-id-type="pmid">34153517</pub-id>
</mixed-citation></ref></ref-list></back></article>